These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35820738)

  • 1. How the Suboxone Education Programme presented as a solution to risks in the Canadian opioid crisis: a critical discourse analysis.
    Sud A; Strang M; Buchman DZ; Spithoff S; Upshur REG; Webster F; Grundy Q
    BMJ Open; 2022 Jul; 12(7):e059561. PubMed ID: 35820738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada.
    Sud A; McGee M; Mintzes B; Herder M
    Int J Drug Policy; 2022 Jul; 105():103749. PubMed ID: 35643048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The opioid crisis: Origins, trends, policies, and the roles of pharmacists.
    Chisholm-Burns MA; Spivey CA; Sherwin E; Wheeler J; Hohmeier K
    Am J Health Syst Pharm; 2019 Mar; 76(7):424-435. PubMed ID: 31361827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders.
    Cox BM; Cote TE; Lucki I
    J Pharmacol Exp Ther; 2019 Nov; 371(2):500-506. PubMed ID: 31320493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic pain management among people who use drugs: A health policy challenge in the context of the opioid crisis.
    Dassieu L; Kaboré JL; Choinière M; Arruda N; Roy É
    Int J Drug Policy; 2019 Sep; 71():150-156. PubMed ID: 30975594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An innovative acute care based intervention to address the opioid crisis in a Canadian setting.
    Imtiaz S; Hayashi K; Nolan S
    Drug Alcohol Rev; 2021 May; 40(4):553-556. PubMed ID: 33047389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
    Doernberg M; Krawczyk N; Agus D; Fingerhood M
    Subst Abus; 2019; 40(2):148-153. PubMed ID: 31008694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada.
    Farrell MacDonald S; Russell C; Beauchamp T; Derkzen D; Fischer B
    Int J Drug Policy; 2022 Feb; 100():103480. PubMed ID: 34656817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Opioid Crisis: The Surgeon's Role.
    Goldberg RF
    Adv Surg; 2019 Sep; 53():305-325. PubMed ID: 31327454
    [No Abstract]   [Full Text] [Related]  

  • 11. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drivers, Beliefs, and Barriers Surrounding Surgical Opioid Prescribing: A Qualitative Study of Surgeons' Opioid Prescribing Habits.
    Sceats LA; Ayakta N; Merrell SB; Kin C
    J Surg Res; 2020 Mar; 247():86-94. PubMed ID: 31767277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of opioid safety initiatives, prescribing patterns for opioid and naloxone, and perceived barriers to prescribing naloxone: Cross-sectional survey results based on practice type, scope, and location.
    Kohan LR; Elmofty D; Pena I; Liao C
    J Opioid Manag; 2021; 17(1):19-38. PubMed ID: 33735425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid agonist treatment (OAT) experiences and release plans among federally incarcerated individuals with opioid use disorder (OUD) in Ontario, Canada: a mixed-methods study.
    Russell C; Nafeh F; Pang M; MacDonald SF; Derkzen D; Rehm J; Fischer B
    BMC Public Health; 2022 Mar; 22(1):436. PubMed ID: 35246083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A rural perspective on the opioid crisis.
    Knox R
    Nurs Manage; 2019 Aug; 50(8):6. PubMed ID: 31361689
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioid Misuse: A Global Crisis.
    Hornberger J; Chhatwal J
    Value Health; 2021 Feb; 24(2):145-146. PubMed ID: 33518020
    [No Abstract]   [Full Text] [Related]  

  • 18. The Opioid Epidemic: Challenge to Military Medicine and National Security.
    Dembek ZF; Chekol T; Wu A
    Mil Med; 2020 Jun; 185(5-6):e662-e667. PubMed ID: 32077961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CAEP Position Statement: Emergency department management of people with opioid use disorder.
    Koh JJ; Klaiman M; Miles I; Cook J; Kumar T; Sheikh H; Dong K; Orkin AM; Ali S; Shouldice E
    CJEM; 2020 Nov; 22(6):768-771. PubMed ID: 33028446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors Associated With Relapse in Individuals With Opioid Use Disorder Receiving Suboxone in Rural Areas.
    Chang YP; Raynor T
    J Addict Nurs; 2021 Jan-Mar 01; 32(1):20-26. PubMed ID: 33646714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.